QFW
REGN icon

QTR Family Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

QTR Family Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$464K Buy
614
+64
+12% +$49K 0.19% 128
2025
Q4 		$415K Buy
550
+147
+36% +$99.8K 0.18% 127
2025
Q3 		$227K Buy
+403
New +$228K 0.11% 220

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

QTR Family Wealth's REGN Position: Q1 2026 in Review

QTR Family Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q1 2026, buying an estimated $49K and bringing the position to 614 shares worth $464K. The position accounts for 0.19% of the portfolio, ranked #128.

QTR Family Wealth first reported a position in REGN in Q3 2025 and has held it in 3 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • QTR Family Wealth held 614 shares of Regeneron Pharmaceuticals worth $464K as of Q1 2026.
  • QTR Family Wealth bought 64 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $49K.
  • Regeneron Pharmaceuticals made up 0.19% of QTR Family Wealth's portfolio in Q1 2026, its #128 holding.
  • QTR Family Wealth first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on QTR Family Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.